Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000930661-02-000605
Filing Date
2002-02-28
Accepted
2002-02-28 00:00:00
Documents
8
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K405 d10k405.txt 10-K405 280647
3 AMENDED AND RESTATED SEVERANCE AGREEMENT dex1030.txt EX-10.30 32398
4 AMENDED AND RESTATED VIROPHARMA STOCK dex1031.txt EX-10.31 147689
5 AMENDED VIROPHARMA INC. EMPLOYEE STOCK PURCH. PLAN dex1032.txt EX-10.32 26000
6 2001 EQUITY INCENTIVE PLAN dex1033.txt EX-10.33 83626
7 FIRST AMENDMENT TO COPROMOTION AND CODEVELOPMENT dex1034.txt EX-10.34 4030
8 SCHEDULE OF RATIO OF EARNINGS TO FIXED CHARGES dex121.txt EX-12.1 1920
9 CONSENT OF KPMG LLP dex23.txt EX-23 1069
  Complete submission text file 0000930661-02-000605.txt   579795
Mailing Address 76 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 405 EAGLEVIEW BLVD PO BOX 5000 EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

EIN.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-21699 | Film No.: 02562641
SIC: 2834 Pharmaceutical Preparations